Table 3.
Mean values of C. albicans and CD biomarkers before surgery and 6 months post-surgery, and significance of their evolution during this period.
| Biological Parameter | Visit | All Patients (n = 23) | p iV vs. V6.mo |
|---|---|---|---|
| Calprotectin | iV | 4.2 (3.3–8.7) | 0.002 |
| V6.mo | 2.2 (1.2–3.4) | ||
| ASCA | iV | 109.2 (76.7–159.0) | <0.0001 |
| V6.mo | 80.6 (67.4–125.1) | ||
| ALCA | iV | 62.6 (45.3–97.7) | 0.113 |
| V6.mo | 53.0 (45.0–82.8) | ||
| ACCA | iV | 51.6 (34.3–69.7) | 0.04 |
| V6.mo | 37.6 (23.2–63.0) | ||
| AMCA | iV | 57.3 (45.1–85.0) | 0.327 |
| V6.mo | 47.4 (38.9–79.8) | ||
| C.albManAb | iV | 6.8 (2.7–9.5) | <0.0001 |
| V6.mo | 3.3 (1.0–6.3) | ||
| C.albProtAb | iV | 0.6 (0.3–2.4) | <0.0001 |
| V6.mo | 0.4 (0.3–0.8) | ||
| Galectin-3 | iV | 10.3 (6.7–11.8) | <0.0001 |
| V6.mo | 6.2 (4.2–9.1) | ||
| MBL | iV | 1032.4 (271.5–2697.2) | 0.283 |
| V6.mo | 1216.0 (304.9–2271.4) |
Values shown are median (interquartile range).